{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:54:53Z","timestamp":1761663293763},"reference-count":26,"publisher":"Japanese Society of Internal Medicine","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/internalmedicine.53.3194","type":"journal-article","created":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T23:35:51Z","timestamp":1417390551000},"page":"2689-2693","source":"Crossref","is-referenced-by-count":14,"title":["Hepatitis C Virus (HCV) Reactivation Caused by Steroid Therapy for Dermatomyositis"],"prefix":"10.2169","volume":"53","author":[{"given":"Nami","family":"Mori","sequence":"first","affiliation":[{"name":"Department of Gastroenterology\/Liver Center, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Imamura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical & Health Science, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Takaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology\/Liver Center, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehisa","family":"Araki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson C.","family":"Hayes","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical & Health Science, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Aisaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology\/Liver Center, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Chayama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical & Health Science, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Maddrey WC. Hepatitis B: an important public health issue. J Med Virol 61: 362-366, 2000."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 6: 35-47, 1999.","DOI":"10.1046\/j.1365-2893.1999.6120139.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61: 1942-1956, 1988.","DOI":"10.1002\/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Magy N, Cribier B, Schmitt C, et al. Effects of corticosteroids on HCV infection. Int J Immunopharmacol 21: 253-261, 1999.","DOI":"10.1016\/S0192-0561(99)00005-3"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Rumi MG, De Filippi F, La Vecchia C, et al. Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c; a retrospective cohort study of 206 untreated patients. Gut 54: 402-406, 2005.","DOI":"10.1136\/gut.2004.048009"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Huang M, Huang L. Reactivation of hepatitis C viral infection after treatment with infliximab. J Clin Gastroenterol 48: 189-190, 2014.","DOI":"10.1097\/MCG.0000000000000001"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Torres HA, Davila M. Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer. Nat Rev Clin Oncol 24: 156-166, 2012.","DOI":"10.1038\/nrclinonc.2012.1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292: 344-347, 1975.","DOI":"10.1056\/NEJM197502132920706"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292: 403-407, 1975.","DOI":"10.1056\/NEJM197502202920807"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ferri C, Sebastiani M, Antonelli A, Colaci M, Manfredi A, Giuggioli D. Current treatment of hepatitis C-associated rheumatic diseases. Arthritis Res Ther 14: 215-226, 2012.","DOI":"10.1186\/ar3865"},{"key":"11","unstructured":"11. Ennishi D, Maeda Y, Niitsu N, et al. Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis. Blood 9: 5119-5125, 2010."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hsieh CY, Huang HH, Lin CY, et al. Rituximab-induced hepatitis C virus reactivation after spontaneous remission in diffuse large B-cell lymphoma. J Clin Oncol 20: 2584-2586, 2008.","DOI":"10.1200\/JCO.2007.15.4807"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Mahale P, Kontoyiannis DP, Chemaly RF, et al. Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol 57: 1177-1185, 2012.","DOI":"10.1016\/j.jhep.2012.07.031"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kawatani T, Suou T, Tajima F, et al. Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies. Eur J Haematol 67: 45-50, 2001.","DOI":"10.1034\/j.1600-0609.2001.067001045.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Coppola N, Pisaturo M, Guastafierro S, et al. Increased hepatitis C viral load and reactivation of liver disease in HCV RNA-positive patients with onco-haematological disease undergoing chemotherapy. Dig Liver Dis 44: 49-54, 2012.","DOI":"10.1016\/j.dld.2011.07.016"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Arcaini L, Merli M, Passamonti F, et al. Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas. Am J Hematol 85: 46-50, 2010.","DOI":"10.1002\/ajh.21564"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ciesek S, Steinmann E, Iken M, et al. Glucocorticosteroids increase cell entry by hepatitis C virus. Gastroenterology 138: 1875-1884, 2010.","DOI":"10.1053\/j.gastro.2010.02.004"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Pitini V, Sturniolo G, Arrigo C, Leonardi S, Pino S, Altavilla G. HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy. Br J Haematol 150: 116-118, 2010.","DOI":"10.1111\/j.1365-2141.2010.08154.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Coppola N, Vatiero LM, Sagnelli E. HCV genotype 2 as a risk factor for reactivation of chronic HCV infection. Gut 54: 1207, 2005.","DOI":"10.1136\/gut.2005.070649"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hiraga N, Suzuki F, Akuta N, et al. Clinical and virological characteristics of untreated patients with chronic hepatitis C who develop serum alanine aminotransferase flare-up. J Med Virol 75: 240-248, 2005.","DOI":"10.1002\/jmv.20263"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lin A, Thadareddy A, Goldstein MJ, Lake-Bakaar G. Immune suppression leading to hepatitis C virus re-emergence after sustained virological response. J Med Virol 80: 1720-1722, 2008.","DOI":"10.1002\/jmv.21257"},{"key":"22","unstructured":"22. Lee WM, Polson JE, Carney DS, Sahin B, Gale M Jr. Reemergence of hepatitis C virus after 8.5 years in a patient with hypogammaglobulinemia: evidence for an occult viral reservoir. J Infect Dis 192: 1088-1092, 2005."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Radkowski M, Gallegos-Orozco JF, Jablonska J, et al. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 41: 106-114, 2005.","DOI":"10.1002\/hep.20518"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kim TW, Kim MN, Kwon JW, et al. Risk of hepatitis B virus reactivation in patients with asthma or chronic obstructive pulmonary disease treated with corticosteroids. Respirology 15: 1092-1097, 2010.","DOI":"10.1111\/j.1440-1843.2010.01798.x"},{"key":"25","unstructured":"25. Du W, Zheng Z, Han S, Ma S, Chen S. HBV reactivation in an occult HBV infection patient treated with prednisone for nephrotic syndrome: case report and literature review. BMC Infect Dis 13: 394, 2013."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Firpi RJ, Nelson DR. Management of viral hepatitis in hematologic malignancies. Blood Rev 22: 117-126, 2008.","DOI":"10.1016\/j.blre.2008.02.001"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/23\/53_53.3194\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:53:10Z","timestamp":1621446790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/23\/53_53.3194\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":26,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.53.3194","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}